Sales decline 9.63% to Rs 828.83 crore
Net profit of Alembic Pharmaceuticals declined 54.88% to Rs 113.83 crore in the quarter ended September 2016 as against Rs 252.27 crore during the previous quarter ended September 2015. Sales declined 9.63% to Rs 828.83 crore in the quarter ended September 2016 as against Rs 917.12 crore during the previous quarter ended September 2015. ParticularsQuarter EndedSep. 2016Sep. 2015% Var.Sales828.83917.12 -10 OPM %20.1437.03 -PBDT166.90339.17 -51 PBT146.64325.92 -55 NP113.83252.27 -55Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content